Until his retirement in summer 2023, Jochen Maas worked in research and development at Sanofi and its predecessor organizations for more than 30 years, most recently as General Manager, Research & Development (R&D) at Sanofi-Aventis Deutschland GmbH. He was Vice President R&D Europe, member of the Global R&D Management Board and responsible for global R&D in the Diabetes division. Jochen Maas was appointed Head of the German R&D-Hub which comprises 1,500 scientists focusing on diabetes and immunology research and several global platform activities in the fields of chemistry, biologicals, toxicology, screening, pharmacokinetics and CMC.
Jochen Maas holds a professorship at the University of Applied Sciences Giessen and gives lectures in pharmacokinetics and drug delivery systems. He is Vice President of the House of Pharma & Healthcare in Frankfurt/Main and an active member of numerous scientific committees and consortia.
From his background, Jochen Maas is a biologist and veterinarian by training and has a doctorate in veterinary medicine including a specification in Radiology. He studied at the Universities of Zurich, Heidelberg and Munich.
